摘要
铁是各种重要生物功能所必需的必需矿物质。尽管对生命至关重要,但铁也具有潜在的毒性方面。铁已被调查为冠状动脉疾病(CAD)的危险因素,然而,铁在CAD患者中的毒性仍然存在争议。铁毒性背后的一种可能机制是“ferroptosis”,一种新描述的铁依赖性细胞死亡形式。 Ferroptosis是铁依赖性调节细胞死亡形式,不同于细胞凋亡,坏死性凋亡和其他类型的细胞死亡。已经报道了在缺血再灌注(I / R)损伤和其他一些疾病中的Ferroptosis。最近,我们报道了ferroptosis是心肌细胞中一种重要的细胞死亡形式。此外,心肌出血是心力衰竭发病机制中的一个重大事件,可以引发游离铁释放到心肌中,并且是心肌梗死后不良左心室重塑的独立预测因子。现在可以用先进的成像方法检测心脏中的铁沉积,例如T2星(T2 *)心脏磁共振成像,其可以非侵入性地预测心肌中的铁水平并检测心肌出血,因此现有技术可用于评估心肌铁。我们将讨论铁在心血管疾病中的作用,特别是心肌I / R损伤
关键词: 心肌梗死,缺血再灌注损伤,铁,活性氧,ferroptosis。
图形摘要
Current Drug Targets
Title:Pathological Roles of Iron in Cardiovascular Disease
Volume: 19 Issue: 9
关键词: 心肌梗死,缺血再灌注损伤,铁,活性氧,ferroptosis。
摘要: Iron is an essential mineral required for a variety of vital biological functions. Despite being vital for life, iron also has potentially toxic aspects. Iron has been investigated as a risk factor for coronary artery disease (CAD), however, iron’s toxicity in CAD patients still remains controversial. One possible mechanism behind the toxicity of iron is “ferroptosis”, a newly described form of irondependent cell death. Ferroptosis is an iron-dependent form of regulated cell death that is distinct from apoptosis, necroptosis, and other types of cell death. Ferroptosis has been reported in ischemiareperfusion (I/R) injury and several other diseases. Recently, we reported that ferroptosis is a significant form of cell death in cardiomyocytes. Moreover, myocardial hemorrhage, a major event in the pathogenesis of heart failure, could trigger the release of free iron into cardiac muscle and is an independent predictor of adverse left ventricular remodeling after myocardial infarction. Iron deposition in the heart can now be detected with advanced imaging methods, such as T2 star (T2*) cardiac magnetic resonance imaging, which can non-invasively predict iron levels in the myocardium and detect myocardial hemorrhage, thus existing technology could be used to assess myocardial iron. We will discuss the role of iron in cardiovascular diseases and especially with regard to myocardial I/R injury.
Export Options
About this article
Cite this article as:
Pathological Roles of Iron in Cardiovascular Disease, Current Drug Targets 2018; 19 (9) . https://dx.doi.org/10.2174/1389450119666180605112235
DOI https://dx.doi.org/10.2174/1389450119666180605112235 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Applications of Biomarkers in Early Clinical Drug Development to Improve Decision-Making Processes
Current Clinical Pharmacology Targeting Prenylated RAS Modifying Enzymes in Cancer Cells
Current Signal Transduction Therapy Preclinical Evaluation of Coronary Stents: Focus on Safety Issues
Current Vascular Pharmacology Diabetes and the Chronic Care Model: A Review
Current Diabetes Reviews Voltage-Gated Sodium Channels: Mutations, Channelopathies and Targets
Current Medicinal Chemistry Understanding Effects of Psychological Stress on Physiology and Disease Through Human Stressome - An Integral Algorithm
Current Bioinformatics Pyrrolo[2,3-d]Pyrimidines as Kinase Inhibitors
Current Medicinal Chemistry Nanomedicines as Cancer Therapeutics: Current Status
Current Cancer Drug Targets Characterization of a Novel Polysaccharide-Iron(III) Complex and Its Anti-Anemia and Nonspecific Immune Regulating Activities
Mini-Reviews in Medicinal Chemistry Coenzyme Q10 in Neuromuscular and Neurodegenerative Disorders
Current Drug Targets Chronopharmaceuticals: Hype or Future of Pharmaceutics
Current Pharmaceutical Design Oxazolidin-2-one as Efficient Ligand for the Copper-Catalyzed N-arylation of Pyrrole, Imidazole and Indole
Letters in Organic Chemistry Patent Selections
Recent Patents on Cardiovascular Drug Discovery Metabolism of HDL and its Regulation
Current Medicinal Chemistry Efficacy of Zofenopril Alone or in Combination with Hydrochlorothiazide in Patients with Kidney Dysfunction
Current Clinical Pharmacology Physical Activity and Diabetic Cardiomyopathy: Myocardial Adaptation Depending on Exercise Load
Current Diabetes Reviews Motility Disorders, Functional Gastrointestinal Disorders, Inflammatory Bowel Disease and Cardiac Rhythm Disturbances - Is there a Link? Review of Literature
Current Drug Targets The V-ATPase as a Target for Antifungal Drugs
Current Protein & Peptide Science ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development
Current Pharmaceutical Design Searching for Phytoinsulins as Cardiovascular Protector in Metabolic Syndrome
Current Pharmaceutical Design